fda tirzepatide shortage Announced Removal of from the Drug List Important Announcement FDA Update on

Ion Layer NAD+ patches: high-dose NAD+ infusions without the needles, at-home, for a fraction of the cost of IVs

Early pregnancy losses and increased incidences of minor visceral (kidney, liver) and skeletal (sternebra) fetal abnormalities were observed at 0.0025 mg/kg/day, at clinically relevant exposures

Tirzepatide Oral Drops Tirzepatide Oral Drops are a compounded, once-weekly, needle-free formulation designed to support weight management, appetite control, and metabolic health

These usually get better in a few days

or Adults with a BMI of 27 or higher who have weight-related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol

the FDA is currently reviewing a requested label expansion to reflect this new use